يعرض 641 - 660 نتائج من 19,590 نتيجة بحث عن '(( significant increase decrease ) OR ( significant ((sex decrease) OR (a decrease)) ))', وقت الاستعلام: 0.53s تنقيح النتائج
  1. 641
  2. 642

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  3. 643

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  4. 644

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  5. 645
  6. 646

    S1 Data - حسب Miki Doi (15347878)

    منشور في 2024
    الموضوعات:
  7. 647

    S1 Fig - حسب Miki Doi (15347878)

    منشور في 2024
    الموضوعات:
  8. 648
  9. 649
  10. 650
  11. 651
  12. 652
  13. 653
  14. 654
  15. 655
  16. 656
  17. 657

    Models 7 to 12: estimation results. حسب Sakar Hasan Hamza (20978818)

    منشور في 2025
    الموضوعات:
  18. 658

    Models 1 to 6: estimation results. حسب Sakar Hasan Hamza (20978818)

    منشور في 2025
    الموضوعات:
  19. 659

    Hausman test results. حسب Sakar Hasan Hamza (20978818)

    منشور في 2025
    الموضوعات:
  20. 660

    Variable’s construction. حسب Sakar Hasan Hamza (20978818)

    منشور في 2025
    الموضوعات: